Related Experiment Video
Updated: Jul 18, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid
Haruhiko Kamiki1, Shin Murakami1, Takashi Nishikaze2
1Laboratory of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyogrid.26999.3d, Tokyo, Japan.
Abstract:
Avian or human influenza A viruses bind preferentially to avian- or human-type sialic acid receptors, respectively, indicating that receptor tropism is an important factor for determining the viral host range. However, there are currently no reliable methods for analyzing receptor tropism biologically under physiological conditions. In this study, we established a novel system using MDCK cells with avian- or human-type sialic acid receptors and with both sialic acid receptors knocked out (KO). When we examined the replication of human and avian influenza viruses in these KO cells, we observed unique viral receptor tropism that could not be detected using a conventional solid-phase sialylglycan binding assay, which directly assesses physical binding between the virus and sialic acids. Furthermore, we serially passaged an engineered avian-derived H4N5 influenza virus, whose PB2 gene was deleted, in avian-type receptor KO cells stably expressing PB2 to select a mutant with enhanced replication in KO cells; however, its binding to human-type sialylglycan was undetectable using the solid-phase binding assay. These data indicate that a panel of sialic acid receptor KO cells could be a useful tool for determining the biological receptor tropism of influenza A viruses. Moreover, the PB2KO virus experimental system could help to safely and efficiently identify the mutations required for avian influenza viruses to adapt to human cells that could trigger a new influenza pandemic. IMPORTANCE The acquisition of mutations that allow avian influenza A virus hemagglutinins to recognize human-type receptors is mandatory for the transmission of avian viruses to humans, which could lead to a pandemic. In this study, we established a novel system using a set of genetically engineered MDCK cells with knocked out sialic acid receptors to biologically evaluate the receptor tropism for influenza A viruses. Using this system, we observed unique receptor tropism in several virus strains that was undetectable using conventional solid-phase binding assays that measure physical binding between the virus and artificially synthesized sialylglycans. This study contributes to elucidation of the relationship between the physical binding of virus and receptor and viral infectivity. Furthermore, the system using sialic acid knockout cells could provide a useful tool to explore the sialic acid-independent entry mechanism. In addition, our system could be safely used to identify mutations that could acquire human-type receptor tropism.
Insights
Scientists developed a new cell system to study how influenza A viruses infect hosts. This method reveals unique viral tropism missed by traditional assays, aiding pandemic preparedness.
Area of Science:
- Virology
- Cell Biology
Background:
- Influenza A virus host range is determined by receptor tropism, specifically binding to avian- or human-type sialic acid receptors.
- Current methods for analyzing biological receptor tropism under physiological conditions are limited.
- Understanding viral receptor tropism is crucial for predicting and preventing influenza pandemics.
Purpose of the Study:
- To establish a novel biological system for analyzing influenza A virus receptor tropism.
- To compare biological receptor tropism with physical binding assays.
- To develop a safe and efficient method for identifying mutations enabling avian influenza viruses to adapt to human cells.
Main Methods:
- Generation of MDCK (Madin-Darby Canine Kidney) cells with avian- or human-type sialic acid receptors knocked out (KO).
- Examination of human and avian influenza virus replication in these KO cells.
- Serial passage of an engineered avian-derived H4N5 influenza virus (PB2 gene deleted) in avian-type receptor KO cells expressing PB2.
Main Results:
- Observed unique viral receptor tropism in KO cells, undetectable by conventional solid-phase sialylglycan binding assays.
- An engineered avian influenza virus mutant showed enhanced replication in KO cells but undetectable binding to human-type sialylglycans.
- The study highlights discrepancies between physical binding and biological infectivity.
Conclusions:
- A panel of sialic acid receptor KO cells is a valuable tool for determining biological receptor tropism of influenza A viruses.
- The PB2 KO virus experimental system can safely identify mutations for avian influenza virus adaptation to human cells.
- This research advances the understanding of virus-receptor interactions and pandemic influenza surveillance.
Related Concept Videos
Influenza
Inhibitors Of Virion Release

